A carregar...
Profile of nintedanib in the treatment of solid tumors: the evidence to date
Angiogenesis is an essential process for tumor growth and metastasis, and remains a promising therapeutic target process in cancer treatment for several cancer types. Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor (VEGF), was the first antiangiogenic agent approve...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4677757/ https://ncbi.nlm.nih.gov/pubmed/26677336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S78805 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|